NCT05645835

Brief Summary

Assess the impact of a remote, app-delivered digital meditation intervention on emotional well-being of lonely older adults. Neuroimaging, electrophysiological (EEG), and autonomic physiology will be used to assess the neural correlates of the intervention. EEG and autonomic physiology will be collected while participants watch 30 min of an awe-inspiring movie. fMRI and autonomic physiology will be collected in the context of a social exploration/exploitation task.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
0mo left

Started Oct 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress98%
Oct 2023Jul 2026

First Submitted

Initial submission to the registry

November 28, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

December 12, 2022

Completed
10 months until next milestone

Study Start

First participant enrolled

October 13, 2023

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 28, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Expected
Last Updated

December 24, 2025

Status Verified

December 1, 2025

Enrollment Period

2.2 years

First QC Date

November 28, 2022

Last Update Submit

December 22, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in the WHO-5 Well-Being Index

    WHO-5 ranges from 0-25, with higher values indicating higher well-being

    Change in well-being from baseline to directly after completing the intervention (6 weeks)

Secondary Outcomes (4)

  • Change in the 20-item UCLA loneliness scale

    Change in loneliness from baseline to directly after completing the intervention (6 weeks)

  • Change in the General Anxiety Disorder-7 (GAD-7)

    Change in anxiety from baseline to directly after completing the intervention (6 weeks)

  • Change in Psychological Stress Measure (PSM-9)

    Change in stress from baseline to directly after completing the intervention (6 weeks)

  • Change in Patient Health Questionnaire (PHQ-9)

    Change in depression from baseline to directly after completing the intervention (6 weeks)

Study Arms (3)

intervention

EXPERIMENTAL

Participants will engage with the digital meditation app delivering the intervention 15 min a day, five days, a week for 6 weeks.

Behavioral: intervention

waitlist control

ACTIVE COMPARATOR

Participants will be randomized to a waitlist group for six weeks. The waitlist control group will then be able to use the meditation app for six weeks as the primary intervention group

Behavioral: waitlist control

Baseline physiology

OTHER

A subset of participants will not participate in the intervention. Only baseline fMRI and EEG data will be collected in these participants.

Other: No Interventions

Interventions

interventionBEHAVIORAL

the digital meditation app will be installed on participants iPad or android. Lonely older adults will use the app five days a week for six weeks total. Neuroimaging will be performed before and after the intervention.

intervention

Participants in the waitlist group will have to wait six weeks after being screened before being able to use the meditation app after the assessment of primary and secondary endpoints

waitlist control

No intervention. Only baseline fMRI and EEG assessment.

Baseline physiology

Eligibility Criteria

Age60 Years - 120 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older
  • English language fluency
  • Naive to meditation practices (not actively meditating more than one hour per month and/or meditation practice for less than a year in their entire life-time)
  • No MRI contra-indications
  • Cognitively healthy (no diagnosis of dementia, stroke, developmental disorders, or major systemic diseases that may impact cognitive function)

You may not qualify if:

  • Below 60 years of age
  • Not fluent in English
  • Active meditator (meditating more than one hour per month and/or meditation practice for more than a year in their entire life-time).
  • Presence of a severe psychiatric (e.g. schizophrenia, bipolar disorder, PTSD), neurological (epilepsy, traumatic brain injury, dementia, multiple sclerosis), or developmental disorder (e.g. autism)
  • Systemic disease (e.g. major recent surgeries, cancer)
  • Claustrophobia
  • Contraindications for MR safety (e.g. metal in body, cochlea implants)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California San Francisco

San Francisco, California, 94158, United States

Location

MeSH Terms

Interventions

Methods

Intervention Hierarchy (Ancestors)

Investigative Techniques

Study Officials

  • Lorenzo Pasquini, PhD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 28, 2022

First Posted

December 12, 2022

Study Start

October 13, 2023

Primary Completion

December 28, 2025

Study Completion (Estimated)

July 1, 2026

Last Updated

December 24, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations